EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GNFT:

25 Sep 2025
LAST:

3.534

CHANGE:
 0.10		OPEN:
3.590		HIGH:
3.630		ASK:
0.000		VOLUME:
12.3K
CHG(%):
2.64		PREV:
3.630		LOW:
3.500		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Sep 253.5903.6303.5003.53412.3K
24 Sep 253.6103.7503.6103.6306K
23 Sep 253.7704.0103.6003.63037.9K
22 Sep 253.9704.1503.9004.15021.2K
19 Sep 254.3304.3304.3304.3302.3K
18 Sep 254.2434.3834.1744.383600
17 Sep 254.1504.2254.1024.2251.5K
16 Sep 254.2704.3104.2704.3002.3K
15 Sep 254.2604.3504.2304.3333.9K
12 Sep 254.2624.3004.2484.2483.4K

COMPANY PROFILE

Name:Genfit S.A. ADR
About:Genfit S.A., a late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2a trial to treat patients with cholangiocarcinoma (CCA); VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia; CML-022; SRT-015, an ASK1 inhibitor targets the inhibition of cellular apoptosis, inflammation, and fibrosis. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
Sector:Healthcare
Industry:Biotechnology
Address:Parc EurasantE, Loos, France, 59120
Website:https://www.genfit.com
CUSIP:372279109
ISIN:US3722791098
FIGI:BBG00NLFGCR9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:112.00
Price to Book:2.78
Price to Sales:3.17
EBITDA:4.69M
Shares:50M
Market Cap:176.72M

TECHNICAL INDICATORS

MA5:3.85
MA10:4.08
MA20:4.05
MA50:4.03
MA100:4.05
MA200:3.87
RSI14:38.53
WPR14:-100.00
MTM14:-0.43
ROC14:-0.11
ATR:0.20
Week High:4.38
Week Low:3.50
Month High:4.38
Month Low:3.50
Year High:6.42
Year Low:2.55
Volatility:48.79